Latest News2019-01-18T13:39:33+00:00

ELIAS News

Olathe biotech moves dog cancer treatment closer to market

A Kansas City-area animal health company is ramping up its efforts to take its cancer immunotherapy treatment to market. Elias Animal Health, a subsidiary of Olathe-based TVAX Biomedical Inc., applied for a conditional licensure of its treatment for dogs with bone cancer through the U.S. Department of Agriculture’s Center for Veterinary Biologics. Elias recently completed preliminary studies of its osteosarcoma treatment and will enroll for a pivotal study as the next step. On Thursday, the company will release the preliminary studies' results, which were promising enough for the company to start the licensing process. “Based on the positive data we’re [...]

June 14th, 2018|

ELIAS gears up for $4m financing with addition of Stephanus and Sewell

ELIAS Animal Health has added considerable expertise to its board as it continues to work towards commercialization of its immunotherapy candidates and an upcoming financing round. The Olathe, Kansas-based firm has appointed Steve Sewell chief operating officer, as well as adding Lee Herron to its scientific advisory board, and Julia Stephanus and Kip Wiggins as board members. Mr. Sewell joins ELIAS after spending 10 years at Mars Petcare. He joined Mars as part of the Greenies brand acquisition and most recently served as market director of Mars Horsecare US. He has an extensive background in sales and marketing leadership in [...]

June 14th, 2018|

ELIAS Animal Health Cancer Immunotherapy Selected for State of the Art Presentation at VCS Mid‐Year Conference

ELIAS Animal Health, a clinical stage development company advancing novel treatments for cancer in companion animals, has been selected by the Veterinary Cancer Society (VCS) for a “State of the Art” presentation at its Mid‐Year Conference in Anchorage, Alaska, March 10‐13. The mid‐year conference is focused on immunotherapy. Brenda Phillips, D.V.M., Dipl. ACVIM (Oncology) will present “T cell‐mediated immunotherapy for common canine cancers” during the state of the art presentation on Sunday, March 11. Dr. Phillips is a board‐certified specialist in medical oncology, practicing with Veterinary Specialty Hospital in San Diego, Calif. The clinical process, ongoing trials, management and experiences [...]

February 12th, 2018|

Related News